Michael Epstein

Michael Epstein

Company: Achilles Therapeutics

Job title: Team Leader, Translational Science


Achilles Therapeutics is developing a personalised cell therapy product to target clonal neoantigens in solid tumours.  Achilles has two open phase I/IIa clinical trials for NCSLC and Melanoma. I am coordinating and leading the statistical analysis on data derived from our Translational Science Programme. I have previously worked in the field of liquid biopsy at Inivata and hold a PhD in Systems Biology from UCL.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.